Legend Stock Future Price Prediction

LEGN Stock  USD 65.32  0.02  0.0306%   
Legend BiotechCorp stock price prediction is an act of determining the future value of Legend BiotechCorp shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Legend BiotechCorp's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Legend BiotechCorp and does not consider all of the tangible or intangible factors available from Legend BiotechCorp's fundamental data. We analyze noise-free headlines and recent hype associated with Legend BiotechCorp, which may create opportunities for some arbitrage if properly timed.
Check out Legend BiotechCorp Basic Forecasting Models to cross-verify your projections. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Legend BiotechCorp based on different types of headlines from major news networks to social media. The Legend stock price prediction module provides an analysis of price elasticity to changes in media outlook on Legend BiotechCorp over a specific investment horizon.
EPS Estimate Current Year
(3.63) 
EPS Estimate Next Year
(3.11) 
Wall Street Target Price
80.9
EPS Estimate Current Quarter
(0.40) 
Quarterly Revenue Growth
(0.12) 
Using Legend BiotechCorp hype-based prediction, you can estimate the value of Legend BiotechCorp from the perspective of Legend BiotechCorp response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Legend BiotechCorp using Legend BiotechCorp's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Legend using crowd psychology based on the activity and movement of Legend BiotechCorp's stock price.
Legend BiotechCorp Asset Turnover is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Asset Turnover of 0.1. As of 5th of June 2023, Current Ratio is likely to grow to 3.70, while Book Value per Share is likely to drop 4.09.

Legend BiotechCorp Short Interest

A significant increase or decrease in Legend BiotechCorp's short interest from the previous month could be a good indicator of investor sentiment towards Legend. Short interest can provide insight into the potential direction of Legend BiotechCorp stock and how bullish or bearish investors feel about the market overall. An investor who is long Legend BiotechCorp may also wish to track short interest. As short interest increases, investors should be becoming more worried about Legend BiotechCorp and may potentially protect profits, hedge Legend BiotechCorp with its derivative instruments, or be ready for some potential downside.
200 Day MA
50.9481
Short Percent
0.0464
Short Ratio
3.7
Shares Short Prior Month
4.1 M
50 Day MA
60.8582

Legend BiotechCorp Hype to Price Pattern

Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Legend BiotechCorp's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Legend BiotechCorp.

Legend BiotechCorp Implied Volatility

    
  65.6  
Legend BiotechCorp's implied volatility exposes the market's sentiment of Legend BiotechCorp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Legend BiotechCorp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Legend BiotechCorp stock will not fluctuate a lot when Legend BiotechCorp's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Legend BiotechCorp. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Legend BiotechCorp to buy its stock at a price that has no basis in reality. In that case, they are not buying Legend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Legend BiotechCorp after-hype prediction price

    
  USD 65.27  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Legend contract

Based on the Rule 16, the options market is currently suggesting that Legend BiotechCorp will have an average daily up or down price movement of about 4.1% per day over the life of the 2023-06-16 option contract. With Legend BiotechCorp trading at USD65.32, that is roughly USD2.68. If you think that the market is fully incorporating Legend BiotechCorp's daily price movement you should consider acquiring Legend BiotechCorp options at the current volatility level of 65.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Legend BiotechCorp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Legend BiotechCorp in the context of predictive analytics.
Intrinsic
Valuation
LowRealHigh
57.0474.8578.49
Details
15 Analysts
Consensus
LowTargetHigh
64.0077.3690.00
Details
Earnings
Estimates (6)
LowProjected EPSHigh
-0.78-0.57-0.36
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Legend BiotechCorp. Your research has to be compared to or analyzed against Legend BiotechCorp's peers to derive any actionable benefits. When done correctly, Legend BiotechCorp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Legend BiotechCorp.

Legend BiotechCorp After-Hype Price Prediction Density Analysis

As far as predicting the price of Legend BiotechCorp at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Legend BiotechCorp or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Legend BiotechCorp, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Legend BiotechCorp Estimiated After-Hype Price Volatility

In the context of predicting Legend BiotechCorp's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Legend BiotechCorp's historical news coverage. Legend BiotechCorp's after-hype downside and upside margins for the prediction period are 61.63 and 68.91, respectively. We have considered Legend BiotechCorp's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 65.32
65.27
After-hype Price
68.91
Upside
Legend BiotechCorp is very steady asset. Analysis and calculation of next after-hype price of Legend BiotechCorp is based on 3 months time horizon.

Legend BiotechCorp Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Legend BiotechCorp is soaring high without any particular reason? This is usually happening because many institutional investors.are aggressively trading Legend BiotechCorp backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Legend BiotechCorp, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.60  3.62  2.02    0.02  7 Events / Month4 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
65.3265.272.98 
107.42  

Legend BiotechCorp Hype Timeline

Legend BiotechCorp is now traded for 65.32. The entity has historical hype elasticity of 2.02 and average elasticity to hype of competition of -0.02. Legend is forecasted to increase in value after the next headline with the price projected to jump to 65.27 or above. The average volatility of media hype impact on the company stock price is about 107.42%. The price boost on the next news is forecasted to be 2.98% whereas the daily expected return is now at 0.6%. The volatility of related hype on Legend BiotechCorp is about 9341.94% with expected price after next announcement by competition of 65.3. The company currently holds 260.93 M in liabilities with Debt to Equity (D/E) ratio of 0.29, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days.
Check out Legend BiotechCorp Basic Forecasting Models to cross-verify your projections. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Legend BiotechCorp Related Hype Analysis

Having access to credible news sources related to Legend BiotechCorp's direct competition is more important than ever and may enhance your ability to predict Legend BiotechCorp's future price movements. Getting to know how Legend BiotechCorp rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Legend BiotechCorp may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GGDVFGuangdong Investment Limited 0.00 0 per month 0.00 (0.05)  4.35 (7.07)  25.06 
UMCUnited Microelectronics 0.16 8 per month 1.56  0.0174  2.86 (2.41)  11.10 
BKHBlack Hills(0.68) 7 per month 1.05  0.0448  2.62 (1.80)  5.27 
SLFSun Life Financial 0.07 9 per month 1.17  0.06  2.20 (1.89)  4.77 
MUMicron Technology(0.70) 5 per month 1.84  0.12  6.11 (3.12)  12.91 
VSHVishay Intertechnology(0.18) 8 per month 1.03  0.15  2.43 (1.63)  18.31 
IGIWestern Asset Investment 0.16 10 per month 0.71  0.0229  1.32 (1.06)  3.73 
MRAMEverspin Technologies 0.86 7 per month 1.92  0.13  5.72 (4.52)  11.94 

Legend BiotechCorp Additional Predictive Modules

Most predictive techniques to examine Legend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Legend using various technical indicators. When you analyze Legend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Legend BiotechCorp Predictive Indicators

The successful prediction of Legend BiotechCorp stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Legend BiotechCorp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Legend BiotechCorp based on analysis of Legend BiotechCorp hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Legend BiotechCorp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Legend BiotechCorp's related companies.

Story Coverage note for Legend BiotechCorp

The number of cover stories for Legend BiotechCorp depends on current market conditions and Legend BiotechCorp's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Legend BiotechCorp is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Legend BiotechCorp's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Legend BiotechCorp Short Properties

Legend BiotechCorp's future price predictability will typically decrease when Legend BiotechCorp's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Legend BiotechCorp often depends not only on the future outlook of the potential Legend BiotechCorp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Legend BiotechCorp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding159 M
Cash And Short Term InvestmentsB
Check out Legend BiotechCorp Basic Forecasting Models to cross-verify your projections. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.26) 
Revenue Per Share
0.639
Quarterly Revenue Growth
(0.12) 
Return On Assets
(0.29) 
Return On Equity
(0.96) 
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.